Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Corticosteroids for mild persistent asthma

Corticosteroids for mild persistent asthma Jay M. Portnoy, MD Boushey HA, Sorkness CA, King TS, et al.: Daily versus bronchodilator, exacerbation frequency, symptom-free as-needed corticosteroids for mild persistent asthma. days, and quality of life. N Engl J Med 2005, 352:1519–1528. Results: Morning peak flows, asthma exacerbations, and Rating: Of outstanding importance. quality of life were the same in all three groups, although patients in the intermittent group took substantially less Introduction: The Nat ional Asthma Education and medication during the year. Budesonide treatment was Prevention Program (NAEPP) guidelines for diagnosis and associated with greater improvement in FEV , sputum treatment of asthma recommend daily controller therapy eosinophils, exhaled nitric oxide, and symptom-free days for patients with mild persistent asthma. In addition, than the LTM or intermittent therapy. patients should be provided with a written action plan. Given the abundant evidence that patients are at most 80% and more commonly 50% adherent with treatment Editor’s comments recommendations, it is more likely that mild persistent asthma is being treated intermittently rather than daily, The reality is that most patients with mild persistent as recommended by the guidelines. asthma take intermittent controller medications when they get worse, regardless of what they are instructed to do. The Aims: http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Allergy and Asthma Reports Springer Journals

Corticosteroids for mild persistent asthma

Portnoy, Jay
Current Allergy and Asthma Reports , Volume 5 (6) – May 27, 2005
Download PDF
1 page

Corticosteroids for mild persistent asthma

Abstract

Jay M. Portnoy, MD Boushey HA, Sorkness CA, King TS, et al.: Daily versus bronchodilator, exacerbation frequency, symptom-free as-needed corticosteroids for mild persistent asthma. days, and quality of life. N Engl J Med 2005, 352:1519–1528. Results: Morning peak flows, asthma exacerbations, and Rating: Of outstanding importance. quality of life were the same in all three groups, although patients in the intermittent group took substantially less Introduction: The Nat ional Asthma...
Loading next page...
 
/lp/springer-journals/corticosteroids-for-mild-persistent-asthma-xtuCJaTsxH

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2005 by Current Science Inc.
Subject
Medicine & Public Health; Allergology; Pneumology/Respiratory System; Otorhinolaryngology; Infectious Diseases
ISSN
1529-7322
eISSN
1534-6315
DOI
10.1007/s11882-005-0019-7
Publisher site
See Article on Publisher Site

Abstract

Jay M. Portnoy, MD Boushey HA, Sorkness CA, King TS, et al.: Daily versus bronchodilator, exacerbation frequency, symptom-free as-needed corticosteroids for mild persistent asthma. days, and quality of life. N Engl J Med 2005, 352:1519–1528. Results: Morning peak flows, asthma exacerbations, and Rating: Of outstanding importance. quality of life were the same in all three groups, although patients in the intermittent group took substantially less Introduction: The Nat ional Asthma Education and medication during the year. Budesonide treatment was Prevention Program (NAEPP) guidelines for diagnosis and associated with greater improvement in FEV , sputum treatment of asthma recommend daily controller therapy eosinophils, exhaled nitric oxide, and symptom-free days for patients with mild persistent asthma. In addition, than the LTM or intermittent therapy. patients should be provided with a written action plan. Given the abundant evidence that patients are at most 80% and more commonly 50% adherent with treatment Editor’s comments recommendations, it is more likely that mild persistent asthma is being treated intermittently rather than daily, The reality is that most patients with mild persistent as recommended by the guidelines. asthma take intermittent controller medications when they get worse, regardless of what they are instructed to do. The Aims:

Journal

Current Allergy and Asthma Reports – Springer Journals

Published: May 27, 2005

There are no references for this article.